Cancer treatment and the KIR–HLA system: an overview
- Authors
- A Kreutzman
- A Lin
- A Lin
- A Lin
- A Moretta
- A Moustaki
- A Serrano
- AD Santin
- AM Mehta
- Angelo Vacca
- AS Gonçalves
- B Klein
- BF Barrier
- CB Bijen
- CC Chang
- CJ Forlenza
- CT Garnett
- D Lehmann
- DC Delgado
- E Sohlberg
- EA Reits
- EM Kruijf de
- EM Kruijf de
- FJ Carretero
- FM Speetjens
- Franco Dammacco
- G Kochan
- H Li
- HG Shilling
- HR MacDonald
- I Riederer
- IH Gabriel
- J Marra
- JM Reuben
- JM Venstrom
- K Beksac
- K Malinowski
- K Stringaris
- K Tada
- KC Hsu
- KC Hsu
- KG Paulson
- L Kleinberg
- L Ruggeri
- L Ruggeri
- L Zitvogel
- L Zitvogel
- LM Kopp
- M Campoli
- M Campoli
- M Chiriva-Internati
- M Gooden
- M Toneva
- M Urosevic
- MA Cooper
- MD Cao
- MD Cao
- MJ Rutten
- MY Cai
- N Tanimine
- OP Joffre
- P Leone
- P Parham
- PA Gourraud
- Patrizia Leone
- R Castriconi
- R Grau
- RD Schreiber
- S Bierer
- S Kim
- S Michelin
- S Mocellin
- SH Hauser
- SM Yie
- SM Yie
- SM Yie
- SR Ye
- T Mariya
- V Re De
- Valli De Re
- Vito Racanelli
- W Leung
- W Leung
- X He
- X Wu
- Y Wang
- Z Abdel-Wahab
- ZF Ma
- ZY Guo
- Publication date
- Publisher
- 'Springer Science and Business Media LLC'
- Doi